China TCM Warns of 2025 Loss on Weaker Granules Business and Higher Impairments
China Traditional Chinese Medicine Holdings Co (HK:0570) has issued a profit warning, expecting a net loss of RMB350 million to RMB500 million for 2025, down from a small profit of RMB20.77 million in 2024. The decline is attributed to weaker performance in its TCM granules business, intensified competition, and increased impairments. Despite these challenges, management indicates that the adjustments are largely non-recurring and will not affect ongoing operations. The current analyst rating is a Hold with a price target of HK$2.00.
Tip Ranks·
